Skip to content

Clinical trials

Phase 1/2 Glucose Intolerance trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Intolerance Phase: Phase 1/2 Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20131
20141
20161
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Medical Center, Cincinnati1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
National Heart, Lung, and Blood Institute (NHLBI)1
The University of Texas Health Science Center at San Antonio1
The University of Texas Health Science Center, Houston1
Tufts Medical Center1
Vanderbilt University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Intolerance7
Obesity2
Cushing Syndrome1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Endocrine System Diseases1
Insulin Resistance1
Metabolic Syndrome1
Overweight1
Prediabetic State1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.